Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Health Care Worker and Community Members From Ethiopian Related to Natural SARS CoV-2 Infection and COVID-19 Vaccination

NCT06435403 is registered in ClinicalTrials.gov with Michael Hoelscher as lead sponsor.

NCT NCT06435403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Health Care Worker and Community Members From Ethiopian Related to Natural SARS CoV-2 Infection and COVID-19 Vaccination
Lead sponsor
Michael Hoelscher
Phase
Observational
Overall status
Unknown status
Start date
November 10, 2022
Completion date
February 28, 2025
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 breakthrough, covid-19 recurrent, sars cov 2 infection